Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 46Stomach Neoplasms 23Pancreatic Neoplasms 21Rectal Neoplasms 16Esophageal Neoplasms 14Adenocarcinoma Of Esophagus 14Colonic Neoplasms 13Neoplasms 11Neoplasm Metastasis 11Carcinoma, Non-Small-Cell Lung 11Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Esophageal Squamous Cell Carcinoma 7Adenocarcinoma 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 5Cholangiocarcinoma 5Lung Neoplasms 4Gastrointestinal Neoplasms 4Endometrial Neoplasms 4Carcinoma, Hepatocellular 4Carcinoma 4Head and Neck Neoplasms 3Breast Neoplasms 3Biliary Tract Neoplasms 3Advanced Solid Tumors 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Oropharyngeal Neoplasms 2Melanoma 2

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Fluorouracil × 90 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡